Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideMRKMerck & Co.
FinDog View：Neutral
| Metric | MRK | MRNA |
|---|
| Close | 144.91 | 145.62 |
| Market Cap | $358B | $58.1B |
| 1M | +6.57% | +125.91% |
| P/E (TTM) | 112.2 | — |
| Forward P/E | 19.5 | — |
| P/E 5-Yr Percentile | 81 | — |
| P/S | 5.4 | 25.8 |
| P/B | 8.5 | 8.5 |
| Dividend Yield | 2.87% | — |
| Latest Quarter Revenue | $16.6B | $145M |
| Revenue YoY | +5.1% | +2.1% |
| Gross Margin | 73.5% | 35.9% |
| Latest Quarter EPS | -0.54 | -1.97 |
| Avg Post-Earnings Move | ±1.7% | ±4.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.50% | — |
| 90-Day Net Insider Buying | −$30.0M | −$49.2M |
MRK · Revenue, Last 8 Quarters ($B)
MRNA · Revenue, Last 8 Quarters ($B)
